Roche turns around diabetes sales
NEW YORK – Roche Diagnostics saw North American diabetes sales of $112 million for the first quarter of 2014, a 13% increase over the same period a year ago, according to news reports. The company’s sales of glucose monitors decreased 16% in 2013, mainly due to Medicare’s national mail-order program for diabetes supplies, which resulted in a reimbursement cut of, on average, 72%. The program kicked of July 1, 2013. Roche tried unsuccessfully to sell its diabetes division last year.